| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $13.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,020 | $46.78 | $468,735.60 | -3.8% | - | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,349 | $48.26 | $499,442.74 | -4.0% | - | - | |
| Mar 11, 2026 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 9,798 | $52.80 | $517,334.40 | -4.0% | - | - | |
| Oct 17, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 50,895 | $67.91 | $3,456,279.45 | -16.7% | -21.6% | - | |
| Oct 14, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 4,242 | $66.60 | $282,517.20 | -2.0% | -20.3% | - | |
| Aug 18, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 13,081 | $58.15 | $760,660.15 | -5.9% | -3.9% | - | |
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 10,031 | $41.23 | $413,578.13 | -4.9% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 14,435 | $42.70 | $616,348.50 | -3.8% | -1.3% | +12.4% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sell | 18,360 | $55.21 | $1,013,563.80 | -9.7% | -26.0% | +3.1% | |
| Feb 19, 2025 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 18,568 | $54.21 | $1,006,580.40 | -4.6% | -26.0% | +3.1% |